Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _____       ___     _    _     _____    ______    __   __  
|  __ \\    / _ \\  | || | ||  |  ___|| |      \\  \ \\/ // 
| |  \ ||  | / \ || | || | ||  | ||__   |  --  //   \ ` //  
| |__/ ||  | \_/ || | \\_/ ||  | ||__   |  --  \\    | ||   
|_____//    \___//   \____//   |_____|| |______//    |_||   
 -----`     `---`     `---`    `-----`  `------`     `-`'   
                                                            
 


Back to frontdoor view